Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
There are currently no randomized clinical trials specifically focused on microdosing
BPC-157 may be worth exploring for: Men recovering from tendon, ligament, or muscle injuries Those experiencing chronic joint pain or inflammation Men on TRT who train intensely and want additional recovery support Individuals with gastrointestinal issues (gut inflammation, leaky gut, NSAID damage) Those interested in peptide therapy as part of a comprehensive wellness protocol Who Should Avoid BPC-157 Anyone with active cancer (BPC-157s angiogenic properties could theoretically promote tumor blood supply) Individuals allergic to any component of the peptide formulation Those unwilling to undergo medical supervision Anyone expecting BPC-157 to replace testosterone therapy for hypogonadism References Sikiric P, Seiwerth S, Rucman R, et al
Reilly, among a bevy of other celebrities
Wegovy is started at a lower dose (0.25mg) and gradually increased over several weeks to the maintenance dose of 2.4mg to minimise gastrointestinal side effects
